The Indian health care space has made substantial progress in the past two decades. A report by the Department of Industrial Policy and Promotion (DIPP) projects that by 2022, India’s health care market will be worth $372 billion. Factors such as higher disposable income, increased health awareness, robust influx of technology, and a notable rise in non-communicable diseases is driving this growth. However, this exuberance fails to mask the fact that numerous deaths occur in India due to preventable diseases. Ventilator-Associated Pneumonia (VAP), for instance, is a condition that claims as many as 250,000 lives in the country, annually. While